Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums

User menu

  • My alerts

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums
  • My alerts
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
Review ArticlePractice

End-of-life issues in advanced dementia

Part 2: management of poor nutritional intake, dehydration, and pneumonia

Marcel Arcand
Canadian Family Physician April 2015, 61 (4) 337-341;
Marcel Arcand
Full Professor in the Department of Family Medicine at the University of Sherbrooke in Quebec, a care of the elderly physician at Institut universitaire de gériatrie de Sherbrooke, and a researcher at the Centre de recherche sur le vieillissement in Sherbrooke.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: marcel.arcand@usherbrooke.ca
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    Figure 1.

    Prognostic score to estimate risk of death within 14 d in patients with dementia and lower respiratory infection or pneumonia when treated with antibiotics

    ©2008 EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, the Netherlands. Reproduced from van der Steen et al,15 with permission from the EMGO Institute for Health and Care Research. Available from: www.emgo.nl/quality-of-our-research/research-tools/prognotische-score.

Tables

  • Figures
    • View popup
    Table 1.

    Guidelines for management of symptoms in end-stage dementia

    SYMPTOMMANAGEMENT
    DyspneaIdentify cause
    • Pneumonia is the most frequent cause; sometimes pulmonary edema

    • Antibiotics might improve comfort (reduce secretions) but prolong dying. Discuss goals of care. If goal of care is comfort but no life prolongation, then “no antibiotics” is appropriate and necessitates good symptom management


    Use opioids, as they are the most effective treatment
    • Start with either 0.5 mg of hydromorphone SC every 4 h as needed or 2–2.5 mg of morphine SC every 4 h in opioid-naive patients

    • If dyspnea is persistent, give doses every 4 h with breakthrough doses (10% of total daily opioid dose given every 1 h)


    Use 20–40 mg of furosemide (SC or IV) if there is evidence of fluid overload
    Use oxygen
    • Oxygen might improve oxygen saturation but it does not improve dyspnea, as it is related to respiratory muscle fatigue. Use oxygen only if the patient is hypoxic and it appears helpful (can be stopped if patient is actively dying and comatose)


    If dyspnea remains severe, prescribe
    • 5–10 mg of midazolam SC plus morphine or hydromorphone 1.5 times the usual 4-h dose plus scopolamine 0.4–0.8 mg and repeat morphine or hydromorphone and midazolam after 20 min as needed


    Prescribe nonpharmacologic therapy
    • Providing a cool draft from an open window or fan and maintaining a calming presence are also helpful

    Terminal rales (“death rattles”)Reposition the patient, as this is often the best strategy
    • Avoid suctioning except superficially without causing gagging. This can be done after lowering the head of the bed for a short time (if tolerated)


    Start pharmacologic treatment
    • 0.2–0.8 mg of scopolamine* SC every 4–6 h as needed (maximum dose is 0.8 mg SC every 2 h)

    • Scopolamine might be more effective if given on a regular basis

    • 0.2 to 0.4 mg of glycopyrrolate SC every 4 h might be preferred (less sedative)

    • 20–40 mg of furosemide SC might help if there is fluid overload

    PainPrescribe opioid (oral or SC administration)
    • Hydromorphone might be preferable because of fewer active metabolites, diminishing risk of opioid toxicity

    • Start opioid slowly: 0.25-0.5 mg of hydromorphone every 4 h (can be given as needed; however, when the patient cannot communicate, low-dose regular medication is often preferable); or 1–2.5 mg of morphine SC every 4 h (second choice)

    • After 24 h, calculate the daily dose needed and give regularly in divided doses with breakthrough doses (half of regular dose) every 1 h

    • Increase regular dosage if > 3 breakthrough doses daily

    AgitationConsider treatable causes of pain (eg, full bladder, fecaloma, dry mouth)
    Consider the following:
    • Often irreversible (might be due to opioid toxicity. Reduce morphine dose or change to hydromorphone, which has fewer active metabolites)

    • Antipsychotics are normally the first choice in delirium (eg, 2.5–5 mg of methotrimeprazine every 6 h as needed), but if agitation is mild to moderate in an actively dying patient, benzodiazepines given regularly (0.5–1 mg of lorazepam SC every 4 h regularly for palliative sedation) might be more useful than antipsychotics

    • If benzodiazepines are ineffective or cause paradoxical excitation, change to 12.5–50 mg of methotrimeprazine over a 24-h period in divided doses every 4–6 h, or 0.5–2 mg of haloperidol SC every 30 min until agitation is controlled, then give regularly every 4–6 h

    Myoclonus (frequent side effect of morphine)Change morphine to hydromorphone and add 0.5 mg of lorazepam every 4 h as needed or regularly
    • IM—intramuscular, IV—intravenous, SC—subcutaneous.

    • ↵* Use of scopolamine or other antimuscarinics in this situation is controversial. Some authors believe that this symptom is not burdensome for the comatose patient and that the treatment might not be in the patient’s interest if used only to comfort family.2

    • Data from van der Maaden et al,2 Ferris et al,11 Twycross et al,19 and Néron.20

PreviousNext
Back to top

In this issue

Canadian Family Physician: 61 (4)
Canadian Family Physician
Vol. 61, Issue 4
1 Apr 2015
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
End-of-life issues in advanced dementia
(Your Name) has sent you a message from The College of Family Physicians of Canada
(Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
End-of-life issues in advanced dementia
Marcel Arcand
Canadian Family Physician Apr 2015, 61 (4) 337-341;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
End-of-life issues in advanced dementia
Marcel Arcand
Canadian Family Physician Apr 2015, 61 (4) 337-341;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Case description
    • Sources of information
    • Main message
    • Case resolution
    • Conclusion
    • Acknowledgments
    • Notes
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

  • Enjeux de fin de vie dans les cas de démence avancée
  • End-of-life issues in advanced dementia
  • PubMed
  • Google Scholar

Cited By...

  • Lexperience dune patiente qui recoit des soins pour la demence: Utiliser << lexperience vecue >> pour ameliorer les soins
  • A patients experience in dementia care: Using the "lived experience" to improve care
  • Enjeux de fin de vie dans les cas de demence avancee: 1re partie : objectifs des soins, processus de prise de decision et education des proches
  • End-of-life issues in advanced dementia: Part 1: goals of care, decision-making process, and family education
  • Google Scholar

More in this TOC Section

Practice

  • Managing type 2 diabetes in primary care during COVID-19
  • Effectiveness of dermoscopy in skin cancer diagnosis
  • Spontaneous pneumothorax in children
Show more Practice

Clinical Review

  • Buprenorphine-naloxone microdosing
  • Approach to hearing loss
  • Approach to diagnosis and management of childhood attention deficit hyperactivity disorder
Show more Clinical Review

Similar Articles

Navigate

  • Home
  • Current Issue
  • Archive
  • Collections - English
  • Collections - Française

For Authors

  • Authors and Reviewers
  • Submit a Manuscript
  • Permissions
  • Terms of Use

General Information

  • About CFP
  • About the CFPC
  • Advertisers
  • Careers & Locums
  • Editorial Advisory Board
  • Subscribers

Journal Services

  • Email Alerts
  • Twitter
  • RSS Feeds

Copyright © 2021 by The College of Family Physicians of Canada

Powered by HighWire